Literature DB >> 19546429

US surveillance of regional lymph node recurrence after breast cancer surgery.

Hee Jung Moon1, Min Jung Kim, Eun-Kyung Kim, Byeong-Woo Park, Ji Hyun Youk, Jin Young Kwak, Joohyuk Sohn, Seung-Il Kim.   

Abstract

PURPOSE: To determine the diagnostic indexes of lymph node ultrasonography (US) of the axillary and supraclavicular regions for detecting lymph node recurrence (LNR) after breast cancer surgery and assess the effect of lymph node evaluation on prognosis during bilateral breast US.
MATERIALS AND METHODS: Institutional review board approved this retrospective study and waived informed consent. Between January 2003 and December 2004, 3982 lymph node US examinations, including bilateral axillary and supraclavicular areas, were performed in 1817 women (mean age, 49.9 years; range, 22-86 years) after breast cancer surgery, nine of whom had palpable lesions. Final diagnosis was based on cytopathologic results, clinical follow-up, and imaging studies for at least 12 months after breast US. Diagnostic indexes of US for detecting LNR were assessed. The frequency of distant metastases between patients with ipsilateral LNR and those without was compared. Three-year mortality rates of patients with ipsilateral LNR only and those with distant metastases were evaluated.
RESULTS: Of 1817 patients, 54 had suspicious LNR at US (28 at first, 20 at second, five at third, and one at fourth US examination). Thirty-nine of 1817 patients (2.1%), including nine with palpable lesions, had LNR, 11 of whom had ipsilateral LNR only. At first lymph node US, LNR was detected in 17 patients; at second, in 10; at third, in two; and at fourth, in one. Nine had false-negative results. The respective sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of lymph node US for detecting LNR per woman was 76.9% (30 of 39), 98.7% (1754 of 1778), 98.2% (1784 of 1817), 55.6% (30 of 54), and 99.5% (1754 of 1763); those of first lymph node US were 85.0% (17 of 20), 99.4% (1786 of 1797), 99.2% (1803 of 1817), 60.7% (17 of 28), and 99.8% (1786 of 1789); and those of total US examinations were 78.0% (32 of 41), 99.4% (3917 of 3941), 99.2% (3949 of 3982), 57.1% (32 of 56), and 99.8% (3917 of 3926). Distant metastases were found more frequently in patients with ipsilateral LNR (62%) than in those without (2.3%) (P < .0001). The 3-year mortality rate of patients with ipsilateral LNR only was significantly lower than that in patients with distant metastases (P = .03).
CONCLUSION: Ipsilateral LNR is a predictor of distant metastasis, and lymph node evaluation during breast US is useful for early detection of LNR in asymptomatic patients.

Entities:  

Mesh:

Year:  2009        PMID: 19546429     DOI: 10.1148/radiol.2523081977

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement.

Authors:  Kevin Diao; Lauren M Andring; Carlos H Barcenas; Puneet Singh; Huong Carisa Le-Petross; Valerie K Reed; Jay P Reddy; Elizabeth S Bloom; Neelofur R Ahmad; Lauren L Mayo; George H Perkins; Melissa P Mitchell; Kevin T Nead; Welela Tereffe; Benjamin D Smith; Wendy A Woodward
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-10-25       Impact factor: 7.038

2.  Palpable Lumps after Mastectomy: Radiologic-Pathologic Review of Benign and Malignant Masses.

Authors:  Rend Al-Khalili; Ali Alzeer; Giang-Kimthi Nguyen; Erin P Crane; Judy H Song; Janice L Jeon; Michael Nellamattathil; Erini V Makariou; Victoria L Mango
Journal:  Radiographics       Date:  2021-05-14       Impact factor: 6.312

Review 3.  Imaging surveillance of patients with breast cancer after primary treatment: current recommendations.

Authors:  Jung Hyun Yoon; Min Jung Kim; Eun-Kyung Kim; Hee Jung Moon
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

4.  Fine-needle aspirate CYFRA 21-1, an innovative new marker for diagnosis of axillary lymph node metastasis in breast cancer patients.

Authors:  Ji Soo Choi; Kyung Hwa Han; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Min Jung Kim
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 5.  Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence.

Authors:  Roberta Piva; Flavia Ticconi; Valentina Ceriani; Federica Scalorbi; Francesco Fiz; Selene Capitanio; Matteo Bauckneht; Giuseppe Cittadini; Gianmario Sambuceti; Silvia Morbelli
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-04

6.  The Usefulness of Ultrasound Surveillance for Axillary Recurrence in Women With Personal History of Breast Cancer.

Authors:  Sung Ui Shin; Jung Min Chang; Jiwon Park; Han-Byoel Lee; Wonshik Han; Woo Kyung Moon
Journal:  J Breast Cancer       Date:  2021-12-03       Impact factor: 3.588

7.  Long-Term Outcomes of Breast Cancer Patients Who Underwent Selective Neck Dissection for Metachronous Isolated Supraclavicular Nodal Metastasis.

Authors:  Shin-Cheh Chen; Shih-Che Shen; Chi-Chang Yu; Ting-Shuo Huang; Yung-Feng Lo; Hsien-Kun Chang; Yung-Chang Lin; Wen-Ling Kuo; Hsiu-Pei Tsai; Hsu-Huan Chou; Li-Yu Lee; Yi-Ting Huang
Journal:  Cancers (Basel)       Date:  2021-12-29       Impact factor: 6.639

8.  Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology.

Authors:  Matthias Hammon; Peter Dankerl; Rolf Janka; David L Wachter; Arndt Hartmann; Rüdiger Schulz-Wendtland; Michael Uder; Evelyn Wenkel
Journal:  BMC Womens Health       Date:  2015-12-03       Impact factor: 2.809

9.  Ultrasound for postoperative surveillance after mastectomy in patients with breast cancer: A retrospective study.

Authors:  Yu-Qing Liu; Jia-Nan Dong; Qing-Xin Meng; Ping Sun; Jing Zhang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

10.  Breast ultrasound in breast cancer surveillance; incremental cancers found at what cost?

Authors:  Luke Bromley; Jennifer Xu; Su-Wen Loh; Grace Chew; Eddie Lau; Belinda Yeo
Journal:  Breast       Date:  2020-11-11       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.